Table 3.
Heart failure management events | Detection of cancer by |
---|---|
Heart failure‐related hospital visits (outpatient and/or admission) | Physical, biochemical and radiological examinations |
Use of oral anticoagulants | Blood loss from tumour prone to bleeding; more sensitive oncological testing |
Cardiovascular risk factor |
Shared risk factors – relevance for cancer detection Regular visits to cardiologist and/or general practitioner |
Shared pathophysiological mechanisms | Knowledge exchange and research may improve cancer awareness in heart failure patients among cardiologists and oncologists; to date unclear if this will translate into better patient management |
Trial inclusion and execution | Cardiovascular and cancer endpoints; state‐of‐the‐art endpoint adjudication |